Long-term response with low-dose of apatinib combined with S-1 in pretreated patient with advanced squamous cell lung cancer: A case report

RATIONALE: Squamous cell lung cancer is one of the major pathological types in patients with non-small cell lung cancer. Since treatment with angiogenic agents and target drugs in patients with advanced squamous cell lung cancer is not promising, there are limited strategies to improve the outcome i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jianxin, Wang, Junhui, Zou, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909226/
https://www.ncbi.nlm.nih.gov/pubmed/33663051
http://dx.doi.org/10.1097/MD.0000000000024390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7909226/
https://www.ncbi.nlm.nih.gov/pubmed/33663051
http://dx.doi.org/10.1097/MD.0000000000024390

Ejemplares similares